Skip to main content

Publications

27 publications

Active

2 grants
  • MPI
    Pilot Research Project: Evaluating Breast Cancer Patient Populations for Therapeutic Targeting of Aberrant p53, MDM2, MDMX, and PARP signaling
    NCI · 2018–2028 · via NIH RePORTER
    U54CA221704-08
  • PI
    The Role of the Mutant p53-PARP-MCM Pathway in Triple Negative Breast Cancer
    NCI · 2020–2026 · via NIH RePORTER
    R01CA239603-05
Completed grants (2)